연구성과로 돌아가기

2023 연구자 정보 (657 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Jang, Tae Won
(Jang, TW) ⓘ 		교신저자 Daegu Catholic Univ, Dept Internal Med, Div Pulm, Med Ctr, Daegu, South Korea
Kosin Univ Gospel Hosp, Dept Internal Med, Div Pulm, Div Gastroenterol, Pusan, South Korea
Kosin Univ Gospel Hosp, Gospel Hosp, Dept Internal Med, Div Pulm, 262 Gamchenro, Pusan 49267, South Korea
Kosin Univ, Coll Med, Gospel Hosp, Dept Internal Med, 262 Gamcheon Ro, Busan 49267, South Korea
Kosin Univ, Kosin Univ Gospel Hosp, Dept Internal Med, Coll Med, 262 Gamcheon Ro, Busan 49267, South Korea
Kosin Univ, Coll Med, Gospel Hosp, Dept Internal Med, Busan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 21.3] Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data
[JCR상위 21.3] Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors
[JCR상위 28.4] Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study ⓘ 		SCIE ⓘ 21.3 ONCOLOGY;RESPIRATORY SYSTEM
ONCOLOGY ⓘ 		jangtw22@hanmail.net;
jangtw22@hanmail.com; ⓘ
Jung, Chi Young
(Jung, CY) ⓘ 		Kyungpook Natl Univ, Dept Internal Med, Div Pulm, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 21.3] Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data ⓘ SCIE ⓘ 21.3 ONCOLOGY;RESPIRATORY SYSTEM ⓘ jangtw22@hanmail.net; ⓘ
Kim, Jehun
(Kim, J) ⓘ 		제1저자 Kosin Univ, Coll Med, Gospel Hosp, Dept Internal Med, 262 Gamcheon Ro, Busan 49267, South Korea ⓘ A-8216-2019
Kim, Woo ⓘ
ⓘ 		[JCR상위 21.3] Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors ⓘ SCIE ⓘ 21.3 ONCOLOGY;RESPIRATORY SYSTEM ⓘ jangtw22@hanmail.com; ⓘ
Kim, Mi Hyun
(Kim, MH) ⓘ 		Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Internal Med, Sch Med, Pusan, South Korea
Biomed Res Inst, Pusan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 21.3] Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors ⓘ SCIE ⓘ 21.3 ONCOLOGY;RESPIRATORY SYSTEM ⓘ jangtw22@hanmail.com; ⓘ
Kim, Seung Joon
(Kim, SJ) ⓘ 		Ulsan Univ, Crit Care Med, Asan Med Ctr, Asan Med Ctr, Seoul, South Korea
Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Pulmonol,Dept Internal Med, Seoul, South Korea
Catholic Univ, Dept Internal Med, Seoul St Marys Hosp, Seoul, South Korea
Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med, Seoul, South Korea ⓘ 		AAK-1840-2021
JDC-5061-2023
Kim, Yong-Joo
Kim, Jung Oh ⓘ 		0000-0003-4836-8958
Kim, Seung Joon ⓘ 		[JCR상위 21.3] Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data
[JCR상위 28.4] Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer
[JCR상위 21.3] Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors
[JCR상위 28.4] Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study ⓘ 		SCIE ⓘ 21.3 ONCOLOGY;RESPIRATORY SYSTEM
ONCOLOGY ⓘ 		jangtw22@hanmail.net;
jclee@amc.seoul.kr;
jangtw22@hanmail.com; ⓘ
Lee, Kye Young
(Lee, KY) ⓘ 		Korea Univ, Guro Hosp, Dept Internal Med, Div Pulm, Seoul, South Korea
Konkuk Univ, Dept Pulm Med, Sch Med, Seoul, South Korea
Konkuk Univ, Dept Internal Med, Med Ctr, Seoul, South Korea
Konkuk Univ, Med Ctr, Dept Internal Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 21.3] Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data
[JCR상위 28.4] Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer
[JCR상위 21.3] Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors
[JCR상위 28.4] Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study ⓘ 		SCIE ⓘ 21.3 ONCOLOGY;RESPIRATORY SYSTEM
ONCOLOGY ⓘ 		jangtw22@hanmail.net;
jclee@amc.seoul.kr;
jangtw22@hanmail.com; ⓘ
Park, Cheol Kyu
(Park, CK) ⓘ 		Chonnam Natl Univ, Dept Internal Med, Med Sch, Hwasun, Jeonnam, South Korea
Hwasun Hosp, Hwasun, Jeonnam, South Korea ⓘ 		AAT-9872-2021
Park, Cheol-Kyu ⓘ
ⓘ 		[JCR상위 21.3] Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors ⓘ SCIE ⓘ 21.3 ONCOLOGY;RESPIRATORY SYSTEM ⓘ jangtw22@hanmail.com; ⓘ
Ryu, Jeong Seon
(Ryu, JS) ⓘ 		Konkuk Univ, Med Ctr, Precis Med Lung Canc Ctr, Seoul, South Korea
Inha Univ Hosp, Dept Internal Med, Incheon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 21.3] Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data
[JCR상위 21.3] Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors
[JCR상위 28.4] Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study ⓘ 		SCIE ⓘ 21.3 ONCOLOGY;RESPIRATORY SYSTEM
ONCOLOGY ⓘ 		jangtw22@hanmail.net;
jangtw22@hanmail.com; ⓘ
Yang, Sei Hoon
(Yang, SH) ⓘ 		Yonsei Univ, Gangnam Severance Hosp, Div Pulm, Dept Internal Med, Seoul, South Korea
Wonkwang Univ, Dept Internal Med, Sch Med, Iksan, South Korea
Wonkwang Univ Hosp, Dept Internal Med, Iksan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 21.3] Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data
[JCR상위 28.4] Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer
[JCR상위 21.3] Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors
[JCR상위 28.4] Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study ⓘ 		SCIE ⓘ 21.3 ONCOLOGY;RESPIRATORY SYSTEM
ONCOLOGY ⓘ 		jangtw22@hanmail.net;
jclee@amc.seoul.kr;
jangtw22@hanmail.com; ⓘ
Ahn, Hyeonjeong
(Ahn, H) ⓘ 		Kyungpook Natl Univ, Dept Stat, Daegu, South Korea ⓘ
ⓘ 		0000-0003-0184-0493
Ahn, Hyeonjeong ⓘ 		[JCR상위 21.4] Mathematical Modeling of COVID-19 Transmission and Intervention in South Korea: A Review of Literature
[JCR상위 28.1] Detection of COVID-19 epidemic outbreak using machine learning ⓘ 		SCIE
SCIE;SSCI ⓘ 		21.4 MEDICINE, GENERAL & INTERNAL
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH ⓘ 		ezhyun@yonsei.ac.kr;
hjlee@knu.ac.kr; ⓘ
Ahn, Tae Hoon
(Ahn, TH) ⓘ 		Gachon Univ, Cardiol, Gil Med Ctr, Incheon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 21.4] Impact of Atrial Fibrillation on Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): The K-TAVI Registry ⓘ SCIE ⓘ 21.4 MEDICINE, GENERAL & INTERNAL ⓘ sh1214.choi@samsung.com; ⓘ
Bae, Woosung
(Bae, W) ⓘ 		Daegu Urban Dev Corp, Daegu 41594, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 21.4] Towards UAVs in Construction: Advancements, Challenges, and Future Directions for Monitoring and Inspection ⓘ SCIE ⓘ 21.4 REMOTE SENSING ⓘ syseo@knu.ac.kr; ⓘ
Bang, Oh. Young
(Bang, OY) ⓘ 		Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurol, Sch Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 21.4] D-dimer to fibrinogen ratio predicts early neurological deterioration in ischemic stroke with atrial fibrillation ⓘ SCIE ⓘ 21.4 HEMATOLOGY;PERIPHERAL VASCULAR DISEASE ⓘ ckkim7@korea.ac.kr; ⓘ
Chang, Kiyuk
(Chang, KY) ⓘ 		Catholic Univ Korea, Seoul St Marys Hosp, Div Cardiol, Dept Internal Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 21.4] Impact of Atrial Fibrillation on Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): The K-TAVI Registry ⓘ SCIE ⓘ 21.4 MEDICINE, GENERAL & INTERNAL ⓘ sh1214.choi@samsung.com; ⓘ
Chen, Bowen
(Chen, BW) ⓘ 		교신저자 Soochow Univ, Sch Elect & Informat Engn, Suzhou 215006, Jiangsu, Peoples R China
Suzhou LZY Technol Co Ltd, Technol Res Inst, Suzhou 215153, Jiangsu, Peoples R China ⓘ 		KFB-3986-2024
Chen, Bowen ⓘ
ⓘ 		[JCR상위 21.4] Selective Resource Offloading in Cloud-Edge Elastic Optical Networks ⓘ SCIE ⓘ 21.4 ENGINEERING, ELECTRICAL & ELECTRONIC;OPTICS;TELECOMMUNICATIONS ⓘ 1184353032@qq.com;bwchen@suda.edu.cn;358892162@qq.com;chenhong2012@suda.edu.cn;mygao@suda.edu.cn;shaowd@suda.edu.cn;jinbing_wu@sina.com;auroraplm@knu.ac.kr;p4ho@uwaterloo.ca; ⓘ
페이지 이동: